Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
19.64
+0.32 (1.66%)
Oct 29, 2026, 9:35 AM EDT - Market open
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of $2.07 billion as of October 29, 2026. It is the 6,507th most valuable company in the world and the 1,764th biggest in the United States. Its market cap has decreased by 6.92% in one year.
Market Cap
2.07B
Enterprise Value
2.35B
1-Year Change
-6.92%
Global Rank
Country Rank
#1,764 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $2.07B, an increase of 3,452.25%. That is a compound annual growth rate of 13.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 2.00B | -11.52% |
| Dec 31, 2025 | 2.26B | -80.58% |
| Dec 31, 2024 | 11.61B | 28.75% |
| Dec 29, 2023 | 9.02B | -20.70% |
| Dec 30, 2022 | 11.37B | 45.06% |
| Dec 31, 2021 | 7.84B | -41.72% |
| Dec 31, 2020 | 13.45B | 39.87% |
| Dec 31, 2019 | 9.62B | 31.90% |
| Dec 31, 2018 | 7.29B | 102.79% |
| Dec 29, 2017 | 3.60B | 140.16% |
| Dec 30, 2016 | 1.50B | -14.27% |
| Dec 31, 2015 | 1.75B | 192.17% |
| Dec 31, 2014 | 597.80M | -21.92% |
| Dec 31, 2013 | 765.60M | 16.58% |
| Dec 31, 2012 | 656.70M | 549.55% |
| Dec 30, 2011 | 101.10M | -57.54% |
| Dec 31, 2010 | 238.10M | 47.70% |
| Dec 31, 2009 | 161.20M | 244.44% |
| Dec 31, 2008 | 46.80M | -38.26% |
| Dec 31, 2007 | 75.80M | -54.99% |
| Dec 29, 2006 | 168.40M | 10.50% |
| Dec 30, 2005 | 152.40M | 79.51% |
| Dec 31, 2004 | 84.90M | -33.15% |
| Dec 31, 2003 | 127.00M | -3.93% |
| Dec 31, 2002 | 132.20M | -47.73% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lakefront Biotherapeutics NV | 2.02B |
| Zymeworks | 2.01B |
| ADARx Pharmaceuticals | 2.00B |
| Maravai LifeSciences Holdings | 1.97B |
| Septerna | 1.93B |
| Vir Biotechnology | 1.87B |
| Palvella Therapeutics | 1.82B |
| Mineralys Therapeutics | 1.82B |